Recent rapid responses
Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.
Displaying 1-2 out of 2 published
24 December 2012
Myself and a few colleagues have set up a website designed to help citizens to ask questions about private screening tests they are offered.
There's an article about why it was set up here
http://www.guardian.co.uk/science/blog/2012/oct/05/private-health-screen...
and this is the link to the website which we hope is useful to people and doctors/nurses
http://privatehealthscreen.org/
Competing interests: I helped write the website referred to and have written a book partly about screening
94 fulton street , Glasgow
22 December 2012
Here in the U.S. we see similar marketing for consumers to get carotid ultrasounds, aortic sonograms, and screening for peripheral artery disease. These tests are offered without adherence to guidelines from relevant societies or organizations, which suggest limiting these studies to specific populations. Patients often end up either worried about the results or falsely reassured by an inadequate understanding of the limitations of such testing.
Competing interests: None declared
none-- I'm in solo practice, 6660 Coyle Ave #250, Carmichael, CA 95608








Re: Restoring invisible and abandoned trials: a call for people to publish the findings
Published 19 June 2013
Re: Austerity policies in Europe—bad for health
Published 19 June 2013
Re: The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers
Published 19 June 2013
Is there a role for agents affecting the GLP-1 system in treatment of type 2 diabetes today? No!
Published 19 June 2013